AbbVie’s Top Lawyer to Remain in Role After Allergan Deal Closes (1)

Jan. 9, 2020, 9:08 PM UTCUpdated: Jan. 9, 2020, 9:46 PM UTC

AbbVie Inc.’s law department leader will keep her job when the company completes its $63 billion mega-merger with fellow drug giant Allergan plc in the first quarter of this year.

Laura Schumacher served as general counsel at AbbVie until December 2018, when she was promoted to become the Chicago-based biopharmaceutical company’s first chief legal officer and vice chairman of external affairs. She will now remain in that position after the Allergan deal closes.

AbbVie announced Jan. 8 that Schumacher will be the sole lawyer occupying the C-suite of the combined company, which will predominantly be led by legacy AbbVie executives. ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.